Hintelmann K, Wahaj S, Henze M, Laakmann E, Muller V, Krug D
Strahlenther Onkol. 2025; .
PMID: 40053136
DOI: 10.1007/s00066-025-02378-z.
Volovat S, Boboc D, Ostafe M, Buzea C, Agop M, Ochiuz L
Tomography. 2025; 11(2).
PMID: 39997998
PMC: 11860310.
DOI: 10.3390/tomography11020015.
OLeary S, Yevudza Jr W, Odiase P, Ammar Haider M, Newsome-Cuby T, Okikioluwa O
Neurooncol Adv. 2025; 7(1):vdae219.
PMID: 39925636
PMC: 11805695.
DOI: 10.1093/noajnl/vdae219.
Rowbottom H, Koncnik R, Ravnik J, Smigoc T
J Clin Med. 2025; 14(2).
PMID: 39860615
PMC: 11766265.
DOI: 10.3390/jcm14020609.
Chen Zhou Z, Salvador Alvarez E, Hilario A, Cardenas Del Carre A, Romero Coronado J, Lechuga C
Eur Radiol. 2025; .
PMID: 39841203
DOI: 10.1007/s00330-025-11363-0.
Radiomic signatures of brain metastases on MRI: utility in predicting pathological subtypes of lung cancer.
Sun L, Luan S, Yu L, Zhu H, Dong H, Liu X
Transl Cancer Res. 2025; 13(12):6825-6836.
PMID: 39816566
PMC: 11729765.
DOI: 10.21037/tcr-24-1147.
Risk factors for brain metastasis in lung cancer: an umbrella review of systematic reviews and meta-analyses.
Wan X, Mo H, Chen J, Zhou Q, Qiu S, Zou Y
BMJ Open. 2025; 15(1):e087181.
PMID: 39773793
PMC: 11749772.
DOI: 10.1136/bmjopen-2024-087181.
Fractionated stereotactic radiotherapy of brainstem metastases - Clinical outcome and prognostic factors.
Kramer A, Hahnemann L, Schunn F, Grott C, Thomas M, Christopoulos P
Clin Transl Radiat Oncol. 2024; 50:100893.
PMID: 39651456
PMC: 11621500.
DOI: 10.1016/j.ctro.2024.100893.
Transfer Learning Approaches for Brain Metastases Screenings.
Luu M, Tuchinov B, Suvorov V, Kenzhin R, Amelina E, Letyagin A
Biomedicines. 2024; 12(11).
PMID: 39595126
PMC: 11591854.
DOI: 10.3390/biomedicines12112561.
Proton pump inhibitor attenuates acidic microenvironment to improve the therapeutic effects of MSLN-CAR-T cells on the brain metastasis.
Zhai X, Mao L, Kang Q, Liu J, Zhou Y, Wang J
Mol Ther. 2024; 33(1):336-355.
PMID: 39511890
PMC: 11764123.
DOI: 10.1016/j.ymthe.2024.11.010.
MicroRNAs in Lung Cancer Brain Metastasis.
Martinez-Espinosa I, Serrato J, Ortiz-Quintero B
Int J Mol Sci. 2024; 25(19).
PMID: 39408656
PMC: 11476622.
DOI: 10.3390/ijms251910325.
Comparative Performance of Autoencoders and Traditional Machine Learning Algorithms in Clinical Data Analysis for Predicting Post-Staged GKRS Tumor Dynamics.
Volovat S, Popa T, Rusu D, Ochiuz L, Vasincu D, Agop M
Diagnostics (Basel). 2024; 14(18).
PMID: 39335770
PMC: 11430838.
DOI: 10.3390/diagnostics14182091.
Malignant melanoma meningeal metastasis with concurrent hemorrhagic cerebrospinal fluid: A case report.
Ma Q, Song B, Cao K, She X, Chen W, Wang W
Oncol Lett. 2024; 28(5):532.
PMID: 39290960
PMC: 11406423.
DOI: 10.3892/ol.2024.14665.
Exposed Phosphatidylserine as a Biomarker for Clear Identification of Breast Cancer Brain Metastases in Mouse Models.
Wang L, Zhao A, Arledge C, Xing F, Chan M, Brekken R
Cancers (Basel). 2024; 16(17).
PMID: 39272945
PMC: 11394599.
DOI: 10.3390/cancers16173088.
Traditional Prostate Cancer Risk Assessment Scales Do Not Predict Outcomes from Brain Metastases: A Population-Based Predictive Nomogram.
Ladner L, Adhikari S, Bhutada A, Cuoco J, Patel V, Entwistle J
Cancers (Basel). 2024; 16(17).
PMID: 39272888
PMC: 11394481.
DOI: 10.3390/cancers16173029.
Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery.
Yavorska M, Tomaciello M, Sciurti A, Cinelli E, Rubino G, Perrella A
J Neurooncol. 2024; 170(3):611-618.
PMID: 39259411
PMC: 11615094.
DOI: 10.1007/s11060-024-04818-9.
Clinical and imaging manifestations of intracerebral hemorrhage in brain tumors and metastatic lesions: a comprehensive overview.
Eminovic S, Orth T, DellOrco A, Baumgartner L, Morotti A, Wasilewski D
J Neurooncol. 2024; 170(3):567-578.
PMID: 39222188
PMC: 11614960.
DOI: 10.1007/s11060-024-04811-2.
Evaluation of the Effect of Radiosurgery for Target and Non-Target Lesions in Patients with Brain Metastases Using RANO-BM Criteria.
Popov V, Raycheva G, Graklanov V, Uchikov P, Grudeva-Popova Z
Technol Cancer Res Treat. 2024; 23:15330338241273324.
PMID: 39196704
PMC: 11363236.
DOI: 10.1177/15330338241273324.
Whole brain radiation therapy for patients with brain metastases: survival outcomes and prognostic factors in a contemporary institutional series.
Estermann A, Schneider C, Zimmermann F, Papachristofilou A, Finazzi T
Strahlenther Onkol. 2024; 200(11):942-948.
PMID: 39134688
PMC: 11527910.
DOI: 10.1007/s00066-024-02275-x.
TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors.
Pearson J, Puig-Saenz C, Thomas J, Hardowar L, Ahmad M, Wainwright L
Cancer Immunol Immunother. 2024; 73(9):178.
PMID: 38954031
PMC: 11219641.
DOI: 10.1007/s00262-024-03770-x.